Atlas Trials

Rotigotine Versus Placebo to Evaluate the Efficacy on Depressive Symptoms in Idiopathic Parkinson's Disease Patients

Clinical trial NCT01523301 · COMPLETED

Trial details

NCT number
NCT01523301
Sponsor
UCB Korea Co., Ltd.
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Idiopathic Parkinson's Disease
Start date
2012-04-01
Primary completion
2014-10-01
Enrollment
380

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.